🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The survey is conducted to investigate the safety and efficacy of long-term...
Status
Completed
Location
Boehringer Ingelheim Investigational Site 119
Start Date
2010-08
Trial ID
NCT01174459
To evaluate the efficacy and safety of long-term treatment with pramipexole...
Status
Completed
Location
Multiple Locations
Start Date
1998-12
Trial ID
NCT00274131
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability and ph...
Status
Recruiting
Location
Huashan Hospital Affiliated to Fudan University
Start Date
2025-11-26
Trial ID
NCT07240675
Treatments Being Tested
The purpose of this study is to compare the effects on depressive symptoms ...
Status
Unknown
Location
University of Louisville, Department of Psychiatry and Behavioral Sciences
Start Date
2019-06-20
Trial ID
NCT03786614
Treatments Being Tested
To assess the bioavailability of dexpramipexole when mixed in soft food and...
Status
Completed
Location
Research Site
Start Date
2012-06
Trial ID
NCT01607034
Treatments Being Tested
Phase 2, open-label, multi-center study to evaluate the clinical effects of...
Status
Completed
Location
ENT Associates of South Florida
Start Date
2014-08
Trial ID
NCT02217332
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-group, dos...
Status
Completed
Location
Research Site
Start Date
2019-08-15
Trial ID
NCT04046939
Treatments Being Tested
Study to document pramipexole dosing during monotherapy, occurrence of fluc...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT02248181
Treatments Being Tested
The primary objective of this study is to investigate the effects on RLS sy...
Status
Completed
Location
248.615.45103 Boehringer Ingelheim Investigational Site
Start Date
2006-07
Trial ID
NCT00349531
Treatments Being Tested
The primary objective of this open-label, flexible dose study is to assess ...
Status
Terminated
Location
248.642.0026 Boehringer Ingelheim Investigational Site
Start Date
2008-05
Trial ID
NCT00681863